HPGDS inhibitor 1
#
-
Catalog numberHY-10439
-
Price:
-
Size100mg
-
-
Alternative_NamesNA
-
CAS1033836-12-2
-
MWt381.37
-
FormulaC19H19F4N3O
-
Solubility10 mM in DMSO
-
Clinical_InformationNo Development Reported
-
PathwayImmunology/Inflammation
-
TargetPGE synthase
-
DescriptionTissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.
-
Gene target
-
Gene symbolHPGDS
-
Short nameHPGDS inhibitor 1
-
Alternative namehematopoietic prostaglandin D synthase suppressor 1
-
Alternative to gene targethematopoietic prostaglandin D synthase, HPGDS and IDBG-30441 and ENSG00000163106 and 27306, protein homodimerization activity, Cytoplasm, Hpgds and IDBG-153041 and ENSMUSG00000029919 and 54486, HPGDS and IDBG-641077 and ENSBTAG00000017073 and 100139892
-
Gene info
-
Identity
-
Gene
-
Long gene namehematopoietic prostaglandin D synthase
-
Synonyms
-
Synonyms name
-
GenBank acession
-
Locus
-
Discovery year2009-07-14
-
Entrez gene record
-
Pubmed identfication
-
RefSeq identity
-
Classification
- Soluble glutathione S-transferases
-
VEGA ID